Envision Healthcare Corporation Stock Price, News & Analysis (NYSE:EVHC)

$30.00 1.01 (3.48 %)
(As of 11/22/2017 02:16 AM ET)
Previous Close$28.99
Today's Range$28.69 - $30.25
52-Week Range$23.77 - $74.75
Volume2.90 million shs
Average Volume2.20 million shs
Market Capitalization$3.51 billion
P/E Ratio8.97
Dividend YieldN/A
Beta0.69

About Envision Healthcare Corporation (NYSE:EVHC)

Envision Healthcare Corporation logoEnvision Healthcare Holdings, Inc., formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc. (EmCare) and American Medical Response, Inc. (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States. Its AMR segment has developed a network of ambulance services and other healthcare transportation services in the United States. It provides Emergency Department (ED) physician services to hospitals and other facilities. Its hospitalist services include inpatient physician services. It provides anesthesiology services to hospitals, free-standing ambulatory surgery centers and physician offices. It provides radiology, including tele-radiology services to hospitals. It offers management, oversight and surgeon staffing for trauma surgery services.


Industry, Sector and Symbol:
  • Industry: Long-Term Care Facilities
  • Sub-Industry: N/A
  • Sector: Medical
  • Symbol: NYSE:EVHC
  • CUSIP: N/A
  • Web: www.evhc.net
Debt:
  • Debt-to-Equity Ratio: 0.89%
  • Current Ratio: 3.01%
  • Quick Ratio: 3.00%
Price-To-Earnings:
  • Trailing P/E Ratio: 8.97
  • Forward P/E Ratio: 11.67
  • P/E Growth: 0.75
Sales & Book Value:
  • Annual Sales: $4.59 billion
  • Price / Sales: 0.79
  • Cash Flow: $2.24 per share
  • Price / Cash: 13.39
  • Book Value: $39.44 per share
  • Price / Book: 0.76
Profitability:
  • Trailing EPS: ($1.49)
  • Net Income: $-18,600,000.00
  • Net Margins: -6.39%
  • Return on Equity: 4.88%
  • Return on Assets: 2.02%
Misc:
  • Employees: 65,200
  • Outstanding Shares: 120,890,000
 

Frequently Asked Questions for Envision Healthcare Corporation (NYSE:EVHC)

What is Envision Healthcare Corporation's stock symbol?

Envision Healthcare Corporation trades on the New York Stock Exchange (NYSE) under the ticker symbol "EVHC."

How will Envision Healthcare Corporation's stock buyback program work?

Envision Healthcare Corporation announced that its Board of Directors has approved a share repurchase plan on Tuesday, September 19th 2017, which authorizes the company to buyback $250,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization authorizes the company to reacquire up to 4.5% of its stock through open market purchases. Stock buyback plans are generally an indication that the company's board believes its shares are undervalued.

How were Envision Healthcare Corporation's earnings last quarter?

Envision Healthcare Corporation (NYSE:EVHC) posted its earnings results on Tuesday, October, 31st. The company reported $0.73 EPS for the quarter, missing analysts' consensus estimates of $0.81 by $0.08. The business earned $1.99 billion during the quarter, compared to the consensus estimate of $2.03 billion. Envision Healthcare Corporation had a positive return on equity of 4.88% and a negative net margin of 6.39%. The firm's revenue for the quarter was up 142.0% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.13 earnings per share. View Envision Healthcare Corporation's Earnings History.

When will Envision Healthcare Corporation make its next earnings announcement?

Envision Healthcare Corporation is scheduled to release their next quarterly earnings announcement on Tuesday, February, 27th 2018. View Earnings Estimates for Envision Healthcare Corporation.

What guidance has Envision Healthcare Corporation issued on next quarter's earnings?

Envision Healthcare Corporation updated its fourth quarter earnings guidance on Tuesday, October, 31st. The company provided EPS guidance of $0.44-$0.54 for the period, compared to the Thomson Reuters consensus estimate of $1.01. The company issued revenue guidance of $1.88-$2.02 billion, compared to the consensus revenue estimate of $2.11 billion.

Where is Envision Healthcare Corporation's stock going? Where will Envision Healthcare Corporation's stock price be in 2017?

15 analysts have issued 12-month price targets for Envision Healthcare Corporation's stock. Their predictions range from $30.00 to $90.00. On average, they anticipate Envision Healthcare Corporation's stock price to reach $45.85 in the next year. View Analyst Ratings for Envision Healthcare Corporation.

What are Wall Street analysts saying about Envision Healthcare Corporation stock?

Here are some recent quotes from research analysts about Envision Healthcare Corporation stock:

  • 1. Cantor Fitzgerald analysts commented, "Early today, Bloomberg reported that EVHC has attracted buyout interest from private equity firms, including Carlyle Group and Onex Corp., which may bid for EVHC alone or as part of a group. Shares rose as much as 14% during the day and closed up 10.3%." (11/14/2017)
  • 2. According to Zacks Investment Research, "Envision Healthcare’s second-quarter earnings beat estimates but declined year over year due to a significant rise in operating expenses. Its differentiated leadership position in each its clinical network solutions provides a pathway to growth in approximately 3,200 hospitals and health systems where it has no presence. Substantial acquisition activity expected to continue in 2017 will aid perfoemance in the Physician service segment. Nevertheless, the company suffers from high indebtedness, which has consequently led to an increase in interest ratio. Also, its operating expense is on the rise and is exceeding revenue growth, which has exerted pressure on operating margins. The company’s shares have underperformed the industry, year to date. The company has also trimmed its 2017 earnings guidance twice so far this year which is worrying." (8/11/2017)
  • 3. Jefferies Group LLC analysts commented, "Investors have been anticipating a volume-driven FY17 guidance miss for the last few months, as evidenced by the discount in its valuation, so last night's guidance shortfall, while wider than expectations, does not come as a surprise. We remain Buy-rated given our view that EVHC's fundamentals are intact; guidance is reasonable/conservative; valuation is compelling, and AMR sale could drive incremental share upside." (3/1/2017)
  • 4. Canaccord Genuity analysts commented, "We maintain our BUY rating on the new EVHC and establish an $86 PT. The recently completed merger of AMSURG and Envision has created a company with unmatched scale in physician services, ambulatory surgery centers (ASCs), and medical transportation. With this combination, EVHC can offer a turn-key solution to health systems while garnering greater negotiating power with payers. The new company has sizable opportunities to cross-sell service lines into existing customers now that the merger is completed, an initiative that is expected to truly begin bearing fruit in 2018. Key highlights: Physician services will be the focus going forward. After recently meeting with mgmt., we walked away believing that physician services growth is the primary focus. The combined businesses of Sheridan and EmCare are now able to sell as one unit. We expect a key target area will be selling anesthesia services into the EmCare customer base as opportunities present. Additionally, mgmt. highlighted that acquisition opportunities remain plentiful. Early this week, EVHC purchased Alabama Neonatal Medicine, a small group that can leverage EVHC’s existing footprint throughout Alabama. What is intriguing about the merger is that the structure, now complete, provides the flexibility to continue to be active on the acquisition front. Ambulatory surgery center steady expansion. Based on our discussions with management, we expect EVHC to add roughly 10-15 ASC’s per year (currently operates 260)." (12/9/2016)

Who are some of Envision Healthcare Corporation's key competitors?

Who owns Envision Healthcare Corporation stock?

Envision Healthcare Corporation's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Janus Henderson Group PLC (3.27%), Artisan Partners Limited Partnership (2.88%), OZ Management LP (2.43%), Dimensional Fund Advisors LP (1.64%), Westfield Capital Management Co. LP (1.04%) and Vaughan Nelson Investment Management L.P. (0.89%). Company insiders that own Envision Healthcare Corporation stock include John Thomas Gawaluck and Robert Jon Coward. View Institutional Ownership Trends for Envision Healthcare Corporation.

Who sold Envision Healthcare Corporation stock? Who is selling Envision Healthcare Corporation stock?

Envision Healthcare Corporation's stock was sold by a variety of institutional investors in the last quarter, including Alyeska Investment Group L.P., Vaughan Nelson Investment Management L.P., Russell Investments Group Ltd., Allianz Asset Management GmbH, Artisan Partners Limited Partnership, Hahn Capital Management LLC, Neuberger Berman Group LLC and Nationwide Fund Advisors. View Insider Buying and Selling for Envision Healthcare Corporation.

Who bought Envision Healthcare Corporation stock? Who is buying Envision Healthcare Corporation stock?

Envision Healthcare Corporation's stock was bought by a variety of institutional investors in the last quarter, including OZ Management LP, Westfield Capital Management Co. LP, American Century Companies Inc., JPMorgan Chase & Co., Dimensional Fund Advisors LP, Ameriprise Financial Inc., Reinhart Partners Inc. and CI Investments Inc.. View Insider Buying and Selling for Envision Healthcare Corporation.

How do I buy Envision Healthcare Corporation stock?

Shares of Envision Healthcare Corporation can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Envision Healthcare Corporation's stock price today?

One share of Envision Healthcare Corporation stock can currently be purchased for approximately $30.00.

How big of a company is Envision Healthcare Corporation?

Envision Healthcare Corporation has a market capitalization of $3.51 billion and generates $4.59 billion in revenue each year. The company earns $-18,600,000.00 in net income (profit) each year or ($1.49) on an earnings per share basis. Envision Healthcare Corporation employs 65,200 workers across the globe.

How can I contact Envision Healthcare Corporation?

Envision Healthcare Corporation's mailing address is 1A BURTON HILLS BOULEVARD, NASHVILLE TN, 37215. The company can be reached via phone at 615-665-1283 or via email at [email protected]


MarketBeat Community Rating for Envision Healthcare Corporation (NYSE EVHC)

Community Ranking:  3.4 out of 5 (star star star)
Outperform Votes:  420 (Vote Outperform)
Underperform Votes:  191 (Vote Underperform)
Total Votes:  611
MarketBeat's community ratings are surveys of what our community members think about Envision Healthcare Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Envision Healthcare Corporation (NYSE:EVHC)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 5 Hold Ratings, 9 Buy Ratings, 1 Strong Buy Rating
Consensus Rating:Buy (Score: 2.73)
Consensus Price Target: $45.85 (52.82% upside)

Consensus Price Target History for Envision Healthcare Corporation (NYSE:EVHC)

Price Target History for Envision Healthcare Corporation (NYSE:EVHC)

Analysts' Ratings History for Envision Healthcare Corporation (NYSE:EVHC)

Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
11/17/2017MizuhoSet Price TargetNeutral -> Neutral$57.00 -> $31.00N/AView Rating Details
11/14/2017Robert W. BairdSet Price TargetBuy$35.00N/AView Rating Details
11/14/2017Cantor FitzgeraldReiterated RatingHold$30.00N/AView Rating Details
11/14/2017KeyCorpSet Price TargetBuy$40.00N/AView Rating Details
11/2/2017Oppenheimer Holdings, Inc.Lower Price TargetOutperform$77.00 -> $40.00N/AView Rating Details
11/2/2017Canaccord GenuityReiterated RatingBuy$68.00 -> $32.00N/AView Rating Details
11/2/2017Citigroup Inc.DowngradeBuy -> Neutral$31.00N/AView Rating Details
11/2/2017StephensDowngradeOverweight -> Equal Weight$32.00N/AView Rating Details
11/2/2017Bank of America CorporationDowngradeBuy -> Neutral$32.00N/AView Rating Details
11/1/2017Jefferies Group LLCSet Price TargetBuy$71.00N/AView Rating Details
10/15/2017SunTrust Banks, Inc.Set Price TargetBuy$55.00N/AView Rating Details
6/27/2017Royal Bank Of CanadaBoost Price TargetOutperform$72.00 -> $77.00LowView Rating Details
3/21/2017Barclays PLCReiterated RatingOverweightLowView Rating Details
12/29/2016Raymond James Financial, Inc.Reiterated RatingStrong-Buy$100.00 -> $90.00N/AView Rating Details
12/9/2016Goldman Sachs Group, Inc. (The)Initiated CoverageBuyN/AView Rating Details
11/2/2016Wells Fargo & CompanyUpgradeMarket Perform -> OutperformN/AView Rating Details
5/8/2016Morgan StanleyReiterated RatingHoldN/AView Rating Details
2/22/2016William BlairReiterated RatingOutperformN/AView Rating Details
12/30/2015Piper Jaffray CompaniesReiterated RatingOverweight$32.00N/AView Rating Details
(Data available from 11/22/2015 forward)

Earnings

Earnings History and Estimates Chart for Envision Healthcare Corporation (NYSE:EVHC)

Earnings by Quarter for Envision Healthcare Corporation (NYSE:EVHC)

Earnings History by Quarter for Envision Healthcare Corporation (NYSE EVHC)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/27/2018        
10/31/2017Q3 2017$0.81$0.73$2.03 billion$1.99 billionViewN/AView Earnings Details
8/7/2017Q2 2017$0.75$0.79$1.96 billion$1.95 billionViewListenView Earnings Details
5/2/2017Q1 2017$0.69$0.69$2.52 billion$1.88 billionViewListenView Earnings Details
2/28/2017Q416$1.20$1.08$1.41 billion$1.39 billionViewListenView Earnings Details
11/1/2016Q316$0.36$0.36$1.67 billion$1.64 billionViewN/AView Earnings Details
8/2/2016Q216$0.36$0.34$1.66 billion$1.64 billionViewN/AView Earnings Details
5/3/2016Q1$0.25$0.28$1.55 billion$1.60 billionViewN/AView Earnings Details
2/24/2016Q415$0.35$0.35$1.45 billion$1.48 billionViewListenView Earnings Details
10/22/2015Q315$0.39$0.30$1.41 billion$1.37 billionViewListenView Earnings Details
8/4/2015Q215$0.35$0.37$1.30 billion$1.35 billionViewListenView Earnings Details
5/5/2015Q115$0.26$0.26$1.19 billion$1.24 billionViewN/AView Earnings Details
2/25/2015Q414$0.36$0.36$1.16 billion$1.16 billionViewN/AView Earnings Details
11/4/2014Q314$0.33$0.35$1.13 billion$1.15 billionViewN/AView Earnings Details
7/31/2014Q214$0.25$0.28$1.04 billion$1.08 billionViewN/AView Earnings Details
4/22/2014Q114$0.19$0.20$1.02 billion$1.01 billionViewN/AView Earnings Details
3/5/2014Q413$0.17$0.20$994.41 million$984.80 millionViewN/AView Earnings Details
11/13/2013Q3 13$0.13$0.13$950.22 million$955.90 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Envision Healthcare Corporation (NYSE:EVHC)
Current Year EPS Consensus Estimate: $2.57 EPS
Next Year EPS Consensus Estimate: $2.96 EPS

Dividends

Dividend History for Envision Healthcare Corporation (NYSE:EVHC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Envision Healthcare Corporation (NYSE EVHC)

Insider Ownership Percentage: 3.10%
Insider Trades by Quarter for Envision Healthcare Corporation (NYSE:EVHC)
Institutional Ownership by Quarter for Envision Healthcare Corporation (NYSE:EVHC)

Insider Trades by Quarter for Envision Healthcare Corporation (NYSE EVHC)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/3/2017Robert Jon CowardInsiderSell1,500$62.69$94,035.00View SEC Filing  
6/22/2017Robert Jon CowardInsiderSell1,500$60.00$90,000.00View SEC Filing  
5/3/2017Robert Jon CowardInsiderSell1,500$60.53$90,795.00View SEC Filing  
4/3/2017Robert Jon CowardInsiderSell1,500$61.34$92,010.00View SEC Filing  
3/10/2017John Thomas GawaluckDirectorBuy1,500$66.65$99,975.00View SEC Filing  
3/1/2017Robert Jon CowardInsiderSell1,500$65.00$97,500.00View SEC Filing  
10/5/2015Leonard M Riggs JrDirectorSell4,000$36.24$144,960.00View SEC Filing  
9/15/2015Randel G OwenCFOSell20,000$42.00$840,000.00View SEC Filing  
9/14/2015William A. SangerCEOSell175,000$41.06$7,185,500.00View SEC Filing  
8/17/2015Randel G OwenCFOSell140,000$44.22$6,190,800.00View SEC Filing  
8/17/2015Todd G ZimmermanCEOSell180,000$44.21$7,957,800.00View SEC Filing  
7/6/2015Leonard M Riggs JrDirectorSell4,000$39.32$157,280.00View SEC Filing  
6/25/2015Dighton PackardInsiderSell40,000$40.00$1,600,000.00View SEC Filing  
4/20/2015Dighton PackardInsiderSell240,188$39.44$9,473,014.72View SEC Filing  
4/16/2015Horne Edward VanInsiderSell10,000$40.00$400,000.00View SEC Filing  
4/16/2015William A SangerCEOSell418,500$40.00$16,740,000.00View SEC Filing  
4/13/2015Craig A WilsonSVPSell18,600$39.57$736,002.00View SEC Filing  
4/13/2015Leonard M Riggs JrDirectorSell4,000$39.57$158,280.00View SEC Filing  
3/19/2015Horne Edward VanInsiderSell12,000$38.00$456,000.00View SEC Filing  
3/19/2015Randel G OwenCFOSell50,000$38.04$1,902,000.00View SEC Filing  
3/16/2015Richard J SchnallDirectorBuy100,000$36.73$3,673,000.00View SEC Filing  
3/9/2015Steven G MurphySVPSell12,021$36.03$433,116.63View SEC Filing  
2/25/2015William A SangerCEOSell153,782$37.50$5,766,825.00View SEC Filing  
2/23/2015William A SangerCEOSell7,100$37.54$266,534.00View SEC Filing  
1/9/2015William A SangerCEOSell194,968$37.52$7,315,199.36View SEC Filing  
1/8/2015Randel G OwenCFOSell200,000$36.56$7,312,000.00View SEC Filing  
10/31/2014Randel G OwenCFOSell19,180$35.00$671,300.00View SEC Filing  
10/28/2014Randel G OwenCFOSell30,820$35.00$1,078,700.00View SEC Filing  
10/24/2014Todd G ZimmermanCEOSell125,000$35.00$4,375,000.00View SEC Filing  
10/22/2014Horne Edward VanInsiderSell6,540$35.00$228,900.00View SEC Filing  
10/6/2014Horne Edward VanInsiderSell10,200$35.00$357,000.00View SEC Filing  
10/1/2014Horne Edward VanInsiderSell10,606$34.67$367,710.02View SEC Filing  
9/29/2014Dighton PackardInsiderSell32,400$34.97$1,133,028.00View SEC Filing  
9/29/2014Michael L SmithDirectorSell7,000$34.97$244,790.00View SEC Filing  
9/29/2014Randel G OwenCFOSell150,000$34.97$5,245,500.00View SEC Filing  
9/29/2014Steve W Ratton JrEVPSell25,000$34.97$874,250.00View SEC Filing  
9/29/2014William A SangerCEOSell200,000$34.97$6,994,000.00View SEC Filing  
9/15/2014Steven G MurphySVPSell45,988$34.75$1,598,083.00View SEC Filing  
7/16/2014Horne Edward VanInsiderSell20,269$32.90$666,850.10View SEC Filing  
7/16/2014Leonard M Riggs JrDirectorSell15,000$32.90$493,500.00View SEC Filing  
7/16/2014Randel G OwenCFOSell249,375$32.90$8,204,437.50View SEC Filing  
7/16/2014Steve W Ratton JrEVPSell42,948$32.90$1,412,989.20View SEC Filing  
7/16/2014Steven G MurphySVPSell21,852$32.90$718,930.80View SEC Filing  
7/16/2014William A SangerCEOSell543,900$32.90$17,894,310.00View SEC Filing  
8/19/2013Leonard M Riggs JrDirectorBuy44,000$23.00$1,012,000.00View SEC Filing  
8/19/2013Steven G MurphySVPBuy5,000$23.00$115,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Envision Healthcare Corporation (NYSE EVHC)

Source:
DateHeadline
Implied Volatility Surging for Envision Healthcare (EVHC) Stock OptionsImplied Volatility Surging for Envision Healthcare (EVHC) Stock Options
finance.yahoo.com - November 21 at 6:39 PM
Robert W. Baird Analysts Give Envision Healthcare Corporation (EVHC) a $35.00 Price TargetRobert W. Baird Analysts Give Envision Healthcare Corporation (EVHC) a $35.00 Price Target
www.americanbankingnews.com - November 19 at 10:20 PM
Envision Healthcare Corporation (EVHC) Expected to Announce Quarterly Sales of $1.98 BillionEnvision Healthcare Corporation (EVHC) Expected to Announce Quarterly Sales of $1.98 Billion
www.americanbankingnews.com - November 19 at 2:54 PM
Envision Healthcare Corporation (EVHC) PT Set at $31.00 by MizuhoEnvision Healthcare Corporation (EVHC) PT Set at $31.00 by Mizuho
www.americanbankingnews.com - November 18 at 2:18 PM
Robbins Arroyo LLP Is Investigating the Officers and Directors of Envision Healthcare Corporation (EVHC) on Behalf ... - Business Wire (press release)Robbins Arroyo LLP Is Investigating the Officers and Directors of Envision Healthcare Corporation (EVHC) on Behalf ... - Business Wire (press release)
www.businesswire.com - November 14 at 11:53 PM
Envision Healthcare Corporations (EVHC) "Hold" Rating Reaffirmed at Cantor FitzgeraldEnvision Healthcare Corporation's (EVHC) "Hold" Rating Reaffirmed at Cantor Fitzgerald
www.americanbankingnews.com - November 14 at 11:03 PM
ETFs with exposure to Envision Healthcare Corp. : November 14, 2017ETFs with exposure to Envision Healthcare Corp. : November 14, 2017
finance.yahoo.com - November 14 at 6:53 PM
Envision Healthcare Corporation (EVHC) Given a $40.00 Price Target at KeyCorpEnvision Healthcare Corporation (EVHC) Given a $40.00 Price Target at KeyCorp
www.americanbankingnews.com - November 14 at 3:18 PM
Robbins Arroyo LLP Is Investigating the Officers and Directors of Envision Healthcare Corporation (EVHC) on Behalf of ShareholdersRobbins Arroyo LLP Is Investigating the Officers and Directors of Envision Healthcare Corporation (EVHC) on Behalf of Shareholders
finance.yahoo.com - November 13 at 6:58 PM
Envision Healthcare Corp. :EVHC-US: Earnings Analysis: Q3, 2017 By the Numbers : November 13, 2017Envision Healthcare Corp. :EVHC-US: Earnings Analysis: Q3, 2017 By the Numbers : November 13, 2017
finance.yahoo.com - November 13 at 10:21 AM
Envision Healthcare Hits 52-Week Low on Q3 Miss, Grim View (Revised) - NasdaqEnvision Healthcare Hits 52-Week Low on Q3 Miss, Grim View (Revised) - Nasdaq
www.nasdaq.com - November 8 at 6:42 AM
Envision Healthcare Hits 52-Week Low on Q3 Miss, Grim View (Revised)Envision Healthcare Hits 52-Week Low on Q3 Miss, Grim View (Revised)
finance.yahoo.com - November 8 at 6:42 AM
Why Envision Healthcare Is Spiraling DownwardWhy Envision Healthcare Is Spiraling Downward
finance.yahoo.com - November 6 at 8:04 PM
Envision Healthcare Corporation (EVHC) Price Target Cut to $35.00Envision Healthcare Corporation (EVHC) Price Target Cut to $35.00
www.americanbankingnews.com - November 5 at 10:18 AM
Envision Healthcare Corporation (EVHC) Receives Consensus Rating of "Buy" from AnalystsEnvision Healthcare Corporation (EVHC) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - November 5 at 3:46 AM
Stock Traders Purchase High Volume of Put Options on Envision Healthcare Corporation (EVHC)Stock Traders Purchase High Volume of Put Options on Envision Healthcare Corporation (EVHC)
www.americanbankingnews.com - November 5 at 1:20 AM
Envision Healthcare Corp. (EVHC) Sank To A New Low After Q3 ReportEnvision Healthcare Corp. (EVHC) Sank To A New Low After Q3 Report
www.rttnews.com - November 3 at 12:41 PM
Envision Healthcare Holdings: S&P 500’s Top Loser on November 1Envision Healthcare Holdings: S&P 500’s Top Loser on November 1
finance.yahoo.com - November 3 at 12:41 PM
Envision Healthcare Corporation (EVHC) Drops the Ball in Q3 ... - Yahoo FinanceEnvision Healthcare Corporation (EVHC) Drops the Ball in Q3 ... - Yahoo Finance
finance.yahoo.com - November 2 at 7:42 PM
Company News For Nov 2, 2017Company News For Nov 2, 2017
finance.yahoo.com - November 2 at 7:42 PM
Envision Healthcare Corporations (EVHC) "Buy" Rating Reaffirmed at Canaccord GenuityEnvision Healthcare Corporation's (EVHC) "Buy" Rating Reaffirmed at Canaccord Genuity
www.americanbankingnews.com - November 2 at 11:02 AM
Corvex, Starboard lose in Einvision Healthcare - Business Insider - Business InsiderCorvex, Starboard lose in Einvision Healthcare - Business Insider - Business Insider
www.businessinsider.com - November 2 at 5:43 AM
Envision Healthcare Corp Enters Oversold Territory - Nasdaq.com - NasdaqEnvision Healthcare Corp Enters Oversold Territory - Nasdaq.com - Nasdaq
www.nasdaq.com - November 2 at 5:43 AM
Envision Healthcare Corp. (EVHC) Is Sinking After Q3 Profit Drops - NasdaqEnvision Healthcare Corp. (EVHC) Is Sinking After Q3 Profit Drops - Nasdaq
www.nasdaq.com - November 2 at 5:43 AM
Edited Transcript of EVHC.N earnings conference call or presentation 1-Nov-17 12:30pm GMTEdited Transcript of EVHC.N earnings conference call or presentation 1-Nov-17 12:30pm GMT
finance.yahoo.com - November 2 at 12:38 AM
Envision Healthcares (EVHC) Q3 Earnings Miss ExpectationsEnvision Healthcare's (EVHC) Q3 Earnings Miss Expectations
www.nasdaq.com - November 1 at 7:35 PM
Envision Healthcare shares plunge after alarming forecastEnvision Healthcare shares plunge after 'alarming' forecast
www.reuters.com - November 1 at 7:35 PM
Envision Healthcare Holdings (EVHC) CEO Christopher Holden on Q3 2017 Results - Earnings Call TranscriptEnvision Healthcare Holdings' (EVHC) CEO Christopher Holden on Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - November 1 at 7:35 PM
Long-Term Envision (EVHC) Investors: Johnson Fistel Investigates Envision Healthcare Corporation; Encourages Long-Term Investors to Contact the FirmLong-Term Envision (EVHC) Investors: Johnson Fistel Investigates Envision Healthcare Corporation; Encourages Long-Term Investors to Contact the Firm
finance.yahoo.com - November 1 at 7:35 PM
Envision Healthcare Fundamentals Are Questionable, Expect A Sell-OffEnvision Healthcare Fundamentals Are 'Questionable,' Expect A Sell-Off
finance.yahoo.com - November 1 at 7:35 PM
Envision Healthcare Corporation (EVHC) Drops the Ball in Q3 Earnings and GuidanceEnvision Healthcare Corporation (EVHC) Drops the Ball in Q3 Earnings and Guidance
finance.yahoo.com - November 1 at 7:35 PM
Envision stock takes a dive as company announces strategic reviewEnvision stock takes a dive as company announces 'strategic review'
finance.yahoo.com - November 1 at 7:35 PM
Why Envision Healthcare Corporation Is Collapsing TodayWhy Envision Healthcare Corporation Is Collapsing Today
www.fool.com - November 1 at 4:41 PM
Mizuho Analysts Give Envision Healthcare Corporation (EVHC) a $57.00 Price TargetMizuho Analysts Give Envision Healthcare Corporation (EVHC) a $57.00 Price Target
www.americanbankingnews.com - November 1 at 1:22 PM
Envision Healthcare Corporation (EVHC) PT Set at $67.00 by KeyCorpEnvision Healthcare Corporation (EVHC) PT Set at $67.00 by KeyCorp
www.americanbankingnews.com - November 1 at 1:22 PM
Envision Q4 Outlook Disappoints, But All Hope Is Not LostEnvision Q4 Outlook Disappoints, But All Hope Is Not Lost
feeds.benzinga.com - November 1 at 12:42 PM
Envision Healthcare Corporation (EVHC) Earns "Hold" Rating from Cantor FitzgeraldEnvision Healthcare Corporation (EVHC) Earns "Hold" Rating from Cantor Fitzgerald
www.americanbankingnews.com - November 1 at 6:34 AM
Envision Healthcare Reviewing Strategic Alternatives - WSJ - Wall Street JournalEnvision Healthcare Reviewing 'Strategic Alternatives' - WSJ - Wall Street Journal
www.wsj.com - November 1 at 5:44 AM
Envision Healthcare (EVHC) Misses Q3 EPS by 15c, to Review Strategic AlternativesEnvision Healthcare (EVHC) Misses Q3 EPS by 15c, to Review Strategic Alternatives
www.streetinsider.com - November 1 at 12:42 AM
Envision Healthcare Reviewing Strategic AlternativesEnvision Healthcare Reviewing 'Strategic Alternatives'
finance.yahoo.com - November 1 at 12:42 AM
Envision Healthcare Reports 2017 Third Quarter Financial ResultsEnvision Healthcare Reports 2017 Third Quarter Financial Results
finance.yahoo.com - October 31 at 7:38 PM
Envision Healthcare misses 3Q profit forecastsEnvision Healthcare misses 3Q profit forecasts
finance.yahoo.com - October 31 at 7:38 PM
Envision Healthcare plummets after earnings miss, may consider saleEnvision Healthcare plummets after earnings miss, may consider sale
finance.yahoo.com - October 31 at 7:38 PM
Envision Healthcare Corporation (EVHC) Announces  Earnings Results, Misses Estimates By $0.09 EPSEnvision Healthcare Corporation (EVHC) Announces Earnings Results, Misses Estimates By $0.09 EPS
www.americanbankingnews.com - October 31 at 7:32 PM
Envision Healthcare Corporation (EVHC) Issues Q4 Earnings GuidanceEnvision Healthcare Corporation (EVHC) Issues Q4 Earnings Guidance
www.americanbankingnews.com - October 31 at 5:40 PM
Monday Sector Laggards: Healthcare, Services - NasdaqMonday Sector Laggards: Healthcare, Services - Nasdaq
www.nasdaq.com - October 31 at 5:15 AM
ETFs with exposure to Envision Healthcare Corp. : October 30, 2017ETFs with exposure to Envision Healthcare Corp. : October 30, 2017
finance.yahoo.com - October 30 at 7:13 PM
Zacks: Brokerages Expect Envision Healthcare Corporation (EVHC) Will Announce Quarterly Sales of $1.99 BillionZacks: Brokerages Expect Envision Healthcare Corporation (EVHC) Will Announce Quarterly Sales of $1.99 Billion
www.americanbankingnews.com - October 30 at 8:23 AM
Will High Costs Dent Envision Healthcare (EVHC) Q3 Earnings? - NasdaqWill High Costs Dent Envision Healthcare (EVHC) Q3 Earnings? - Nasdaq
www.nasdaq.com - October 29 at 4:55 AM
Will High Costs Dent Envision Healthcare (EVHC) Q3 Earnings?Will High Costs Dent Envision Healthcare (EVHC) Q3 Earnings?
finance.yahoo.com - October 27 at 8:43 PM

Social Media

Financials

Chart

Envision Healthcare Corporation (NYSE EVHC) Chart for Wednesday, November, 22, 2017
Loading chart…

This page was last updated on 11/22/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.